Epidemic of <it>Klebsiella pneumoniae</it> ST11 Clone Coproducing KPC-2 and 16S rRNA Methylase RmtB in a Chinese University Hospital

• Main Authors: Li Jun-Jie, Sheng Zi-Ke, Deng Mei, Bi Sheng, Hu Fei-Shu, Miao Hai-Feng, Ji Zhong-Kang, Sheng Ji-Fang, Li Lan-Juan
• Format: Article
• Language: English
• Published: BMC 2012-12-01
• Series: BMC Infectious Diseases
• Subjects: Carbapenem; Aminoglycoside; KPC; <it>rmtB</it>; Epidemic
• Online Access: http://www.biomedcentral.com/1471-2334/12/373

<p>Abstract</p> <p>Background</p> <p>Emergence of <it>rmtB</it>-positive <it>Klebsiella pneumoniae</it> carbapenemase (KPC)-producing <it>K. pneumoniae</it> (KPC-KP) poses a great threat to antimicrobial treatment options.</p> <p>Methods</p> <p>From January 2010 to December 2010, non-duplicate KPC-KP isolates from our hospital were screened for <it>rmtB</it> and multiple other resistance determinants with PCR. Subsequent studies included MIC determination, PFGE, and multilocus sequence typing. Records from patients with KPC-KP isolated were retrospectively reviewed. Comparisons of molecular and clinical characteristics between <it>rmtB-</it>positive and <it>rmtB</it>–negative isolates were systematically performed, as well as the environmental colonization study in ICU wards.</p> <p>Results</p> <p>A total of 84 KPC-KP strains were collected, including 48 <it>rmtB</it>-positive KPC-KP (RPKP) and 36 <it>rmtB</it>-negative KPC-KP (RNKP) isolates. All KPC-KP isolates were multidrug resistant, with colistin and tigecycline being the most active agents. Compared with RNKP, RPKP displayed a much severer resistance phenotype. Susceptibility rates for amikacin (0% for RPKP versus 88.9% for RNKP, <it>p</it> < 0.01), fosfomycin (8.5% for RPKP versus 88.9% for RNKP, <it>p</it> < 0.01), and minocycline (6.7% for RPKP versus 52.8% for RNKP, <it>p</it> < 0.01), were all significantly lower in RPKP strains. Isolates belonging to PFGE pulsetype A and sequence type 11 were predominant in both groups, including 39 (81.3%) RPKP and 22 (61.1%) RNKP isolates. Nevertheless, RNKP showed more complex genetic backgrounds compared with RPKP. Diverse clinical characteristics were found in both cohorts, however, no significant differences were observed between RPKP and RNKP patients.</p> <p>Conclusions</p> <p>RPKP strains have spread widely and gradually replaced RNKP in our hospital. They seemed to show much severer resistance phenotypes compared with RNKP and had a bigger dissemination potential. Prudent use of available active agents combined with good control practices is therefore mandatory.</p>